Bayer's Cipro Patent Ethics During the Anthrax Crisis
This paper examines the ethical and corporate dilemma Bayer faced regarding its patent on Cipro during the post-9/11 anthrax scare. Drawing on utilitarian and consequentialist ethical frameworks, the paper argues that Bayer should have voluntarily and temporarily suspended its patent to build public goodwill while protecting long-term shareholder value. The analysis also addresses Bayer's labeling responsibilities under FDA guidelines and the broader legitimacy of pharmaceutical patent protection in the United States. The paper concludes that voluntary patent suspension, combined with strong consumer safety messaging aligned with CDC recommendations, represented the most strategically and ethically sound course of action available to the company.
- Introduction: Shareholder Interests and Corporate Ethics: Framing Bayer's decision around patents and ethics
- Ethical Frameworks and the Cipro Patent Dilemma: Utilitarian and consequentialist views on patent release
- The Case for Voluntary Patent Suspension: Goodwill and shareholder benefits of suspending patent
- Labeling Responsibilities and Consumer Safety: FDA compliance and boosted Cipro consumer warnings
- The Legitimacy of Pharmaceutical Patent Profits: Moral legitimacy of profiting from public health crises
- Conclusion and Recommended Course of Action: Final recommendation for decisive Bayer leadership
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper applies named ethical frameworks — utilitarianism and consequentialism — directly to a concrete corporate decision, grounding abstract theory in a real-world scenario.
- It balances competing stakeholder interests (shareholders, the public, government regulators) without dismissing any perspective, which strengthens the credibility of its conclusion.
- The use of a legal precedent (Wyeth v. Levine) and academic sources on patent theory adds disciplinary breadth appropriate for a business ethics argument.
Key academic technique demonstrated
The paper demonstrates applied ethical reasoning — the practice of selecting and deploying established normative frameworks to evaluate a specific business decision. Rather than merely describing what happened, the author tests the situation against both utilitarian and consequentialist lenses and shows where they converge, lending logical force to the final recommendation.
Structure breakdown
The paper opens by defining the decision context (shareholder vs. ethical obligations), then moves through competing ethical frameworks, arrives at a policy recommendation (voluntary suspension), and addresses ancillary operational issues (labeling, CDC compliance). It closes with a concise summary reiterating the core recommendation. This problem–analysis–recommendation structure is characteristic of applied business ethics writing at the undergraduate level.
Introduction: Shareholder Interests and Corporate Ethics
Bayer must make its decision on an appropriate course of action in the context of two key variables: shareholder interests and corporate ethics. Bayer's indecision was the worst of both worlds — it resulted in considerable erosion of goodwill, and a suspension of the patent would not have been in the best interests of shareholders under a reactive, forced scenario. Patents exist to protect intellectual property, and this holds even in the event of a public health crisis. Bayer has an obligation to protect its intellectual property rights because doing so serves the interests of shareholders. The only reason not to uphold these property rights is if doing so would create such a negative public perception of the company as to damage the business in the long run.
Works Cited
Wyeth v. Levine. 2008. Supreme Court of the United States. Retrieved November 15, 2009 from
Dunne, A. (no date). Rent seeking and the social cost of monopoly. Trinity College of Dublin. Retrieved November 15, 2009 from
Sterckx, S. (2006). The moral justifiability of patents. Ethical Perspectives. Retrieved November 15, 2009 from
Create your account
Always verify citation format against your institution’s current style guide requirements.